Hypofractionated radiotherapy for prostate cancer (HYDRA): an individual patient data meta-analysis of randomised trials in the MARCAP consortium
Amar U. Kishan, Yilun Sun, Alison Tree, Emma Hall, David P. Dearnaley, Charles Catton, Himanshu R Lukka, Gregory R. Pond, W. Robert Lee, Howard M. Sandler, Felix Y. Feng, Paul L. Nguyen, Luca Incrocci, Wilma D. Heemsbergen, Floris J. Pos, Eric Horwitz, J.K. Wong, Karen E. Hoffman, Comron Hassanzadeh, Deborah A. Kuban, Stefano Arcangeli, Giuseppe Sanguineti, S. Supiot, G. Créhange, I. Latorzeff, Tahmineh Romero Kalbasi, Michael L. Steinberg, Luca Valle, Andrew Loblaw, John Nikitas, Soumyajit Roy, Nicholas G. Zaorsky, Angela Y. Jia, Daniel E. Spratt
Topics & Concepts
Prostate cancerMedicineLernaean HydraMeta-analysisRadiation therapyOncologyCancerInternal medicineBiologyCell biologyProstate Cancer Diagnosis and TreatmentAdvanced Radiotherapy TechniquesProstate Cancer Treatment and Research